Status:
COMPLETED
Knee Osteoarthritis Treatment With Adipose-derived Stem Cells: Phase II Clinical Trial
Lead Sponsor:
King Faisal Specialist Hospital & Research Center
Conditions:
Knee Osteoarthritis
Eligibility:
All Genders
45-65 years
Phase:
PHASE2
Brief Summary
In 1990, the prevalence of osteoarthritis of the hip or knee was very low 3.5% in Saudi Arabia, it increased to 53.3% and 60.9% in male in female patients respectively in 2002. The existing management...
Detailed Description
STUDY DESIGN, LOCATION AND PATIENTS This study will be a single center phase II one arm clinical trial. It will be conducted at King Faisal Specialist Hospital \&Research Center (Gen. Org.)-Jeddah. Th...
Eligibility Criteria
Inclusion
- age between 45 and 65.
- Participants having Knee osteoarthritis grade 2 or higher "Kellgren and Lawrence scale"
- Participants had an average pain intensity of grade 4 or more on a 10-point visual analog for at least one year.
Exclusion
- Patient with history of rheumatic or chronic inflammatory diseases
- Patient poorly controlled diabetes,
- Patient who currently on OA treatment such as corticosteroids, chondroitin sulfate, glucosamine or hyaluronic acid.
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 12 2023
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT03308006
Start Date
January 1 2018
End Date
April 12 2023
Last Update
April 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
King Faisal Sepcialist Hospital and Research Center
Jeddah, Saudi Arabia